GLP-1 Coverage Doesn’t Have to be All or Nothing
WW RxFlexFund™ helps employers offer GLP-1 coverage with flexible subsidies, wraparound care, and predictable costs without breaking benefits budgets.
New clinical insights reveal how holistic weight management support impacts employees’ daily functioning and work performance in measurable ways.
Scientifically reviewed by Kelli Richardson
As we look back at our 2025 highlight reel, it’s not our accomplishments that grab our attention. It’s our clients meeting their objectives — driving sustainable health outcomes while managing costs. And it’s meeting our members where they are on their weight health journeys.
Sure, we rolled out new programs, new tools, and new ways to get healthier and feel better. But none of that really matters without our members, who — for the 365 days — showed up for themselves, showed up for each other, and showed zero quit.
Goals Achieved: The 2025 Highlights
GLP-1 Success Program
Weight-loss meds work better with Weight Watchers Med+ — and members of our clinic services know this firsthand:
And just in time for 2026…
Our innovative WW RxFlexFund™ balances cost predictability with clinically proven care. This first-of-its kind solution unlocks pharma-direct pricing and GLP-1 cost sharing. Employers cover the cost of Weight Watchers Med+ clinic and contribute a set percentage of medication costs, ranging from 25% to 75%, to help offset the impact of GLP-1 medication costs for their employees. This program is integrated with behavioral and clinical support, offering employees a comprehensive path to lasting results. Employers no longer have to choose between GLP-1 coverage and cost containment.
Helping members shift their life stories
Whether they’re on medications, off meds, living with diabetes or in menopause, Weight Watchers has a plan that works for your employees.
Diabetes program
WeightWatchers makes living with diabetes easier. The tailored app includes blood-sugar tracking for type 2 diabetes and the proven nutrition program helps lower A1C.2
New! WW Med+ for Menopause program
Our members on hormone therapy reported a 52.5% reduction in severity of menopause symptoms after just one month on the WW Med+ for Menopause program.3
Innovation that boosts motivation
Surrounded by support
Weight Watchers Connect our members-only digital community is a whole new way for employees to experience the support of the WW community and swap tips, post photos, celebrate progress, and more!
- 880,000 posts
- 129 million comments and reactions
Top trending tags
#goforthegoal – When summer comes around, this challenge heats things up.
#bettertogether – Used as a way to show support to other members, this tag speaks volumes about the power of community.
#walkingweek – Back for its 6th year, this challenge is about creating a daily walk ritual
161,930 total Workshops held
- 83% of Workshops members say, "Workshops made me more successful on my weight-loss journey."4
The right partner makes all the difference. Let’s work together to tailor a solution that fits your objectives, drives sustainable health outcomes, and manages costs in 2026 and beyond!
1 Based on an internal analysis of 3,260 Weight Watchers Med+ clinic members prescribed a GLP-1 medication and self-reported both a starting weight and a weight at month 12. On average members lost 21.0% of body weight in 12 months. Compared to an analysis of (i) 17,475 Calibrate members who received at least one month of GLP-1 medication, were enrolled and had a valid weight at month 12, and lost 15.7% body weight in 12 months; (ii) an analysis of 500+ Form Health patients who received intensive lifestyle therapy and semaglutide, and had an average weight loss 13.6% body weight in 12 months; and (iii) an analysis of 1,812 Hims & Hers members prescribed a compounded injectable GLP-1 medication through the Hims & Hers platform, reported their weight at month 12, and lost an average of 12.2% body weight in 12 months. Cohorts differed in inclusion criteria, medication type, and follow-up duration. Not randomized, controlled clinical trials. Self-reported outcomes have not been independently verified. Individual results may vary.
2 Based on a 6-month multicenter study demonstrating significant changes in weight, blood sugar, blood pressure, waist circumference, and quality of life. Apolzan JW et al. A Scalable, Virtual Weight Management Program Tailored for Adults with Type 2 Diabetes: Effects on Glycemic Control. Nutrition & Diabetes. 2023. Funded by WW International, Inc.
3 Internal analysis of 142 Med+ for Menopause members showed average symptom scores decreased from 22.1 to 10.5 (out of 40) after ~44 days. Not a randomized, controlled trial. Self-reported outcomes. Individual results may vary.
4 Based on survey responses from 726 current or lapsed Weight Watcher members in the U.S. who engage with the WW app or website at least a few times per month and have tried to lose weight in the past 2 years.
